Douglas Kell has been named chief executive of the UK's Biotechnology and Biological Sciences Research Council for a four-year period.
Kell is professor of bioanalytical science at the University of Manchester and director of the Manchester Centre for Integrative Systems Biology, where he will continue to work one day a week when he takes on his new position in October.
Medco Health Solutions has appointed Felix Frueh to be VP of research and development, personalized medicine.
Frueh was formerly associate director for genomics at the US Food and Drug Administration's Office of Clinical Pharmacology in the Center for Drug Evaluation and Research. He also was chair of the FDA's Interdisciplinary Pharmacogenomics Review Group.